Concomitant weekly cisplatin and thoracic radiotherapy for pancoast tumors of the lung: Pilot experience of the San Antonio Cancer Institute

Jonathan B. Barnes, Scott B. Johnson, Rajiv S. Dahiya, R. Thomas Temes, Terence S. Herman, Charles Thomas

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Pancoast (superior sulcus tumors) comprise a subset of non-small-cell lung cancers that have a unique clinical presentation by virtue of the locoregional pattern of disease progression. We herein report a brief report on our group's pilot experience in managing these challenging lung neoplasms with an aggressive concomitant modality approach. These results and those of the recent Southwest Oncology-lead Intergroup prospective phase 2 trial (SWOG-9416/INT-0160) support the use of concomitant chemoradiation followed by an attempt at surgical resection.

Original languageEnglish (US)
Pages (from-to)90-92
Number of pages3
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume25
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Pancoast Syndrome
Non-Small Cell Lung Carcinoma
Cisplatin
Disease Progression
Lung Neoplasms
Radiotherapy
Thorax
Lung
Neoplasms
iodonitrotetrazolium
Lead

Keywords

  • Concomitant chemoradiation
  • Pancoast
  • Superior sulcus

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Concomitant weekly cisplatin and thoracic radiotherapy for pancoast tumors of the lung : Pilot experience of the San Antonio Cancer Institute. / Barnes, Jonathan B.; Johnson, Scott B.; Dahiya, Rajiv S.; Temes, R. Thomas; Herman, Terence S.; Thomas, Charles.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, No. 1, 2002, p. 90-92.

Research output: Contribution to journalArticle

@article{a6696807edc24bacbc098bd89a5a259d,
title = "Concomitant weekly cisplatin and thoracic radiotherapy for pancoast tumors of the lung: Pilot experience of the San Antonio Cancer Institute",
abstract = "Pancoast (superior sulcus tumors) comprise a subset of non-small-cell lung cancers that have a unique clinical presentation by virtue of the locoregional pattern of disease progression. We herein report a brief report on our group's pilot experience in managing these challenging lung neoplasms with an aggressive concomitant modality approach. These results and those of the recent Southwest Oncology-lead Intergroup prospective phase 2 trial (SWOG-9416/INT-0160) support the use of concomitant chemoradiation followed by an attempt at surgical resection.",
keywords = "Concomitant chemoradiation, Pancoast, Superior sulcus",
author = "Barnes, {Jonathan B.} and Johnson, {Scott B.} and Dahiya, {Rajiv S.} and Temes, {R. Thomas} and Herman, {Terence S.} and Charles Thomas",
year = "2002",
doi = "10.1097/00000421-200202000-00019",
language = "English (US)",
volume = "25",
pages = "90--92",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Concomitant weekly cisplatin and thoracic radiotherapy for pancoast tumors of the lung

T2 - Pilot experience of the San Antonio Cancer Institute

AU - Barnes, Jonathan B.

AU - Johnson, Scott B.

AU - Dahiya, Rajiv S.

AU - Temes, R. Thomas

AU - Herman, Terence S.

AU - Thomas, Charles

PY - 2002

Y1 - 2002

N2 - Pancoast (superior sulcus tumors) comprise a subset of non-small-cell lung cancers that have a unique clinical presentation by virtue of the locoregional pattern of disease progression. We herein report a brief report on our group's pilot experience in managing these challenging lung neoplasms with an aggressive concomitant modality approach. These results and those of the recent Southwest Oncology-lead Intergroup prospective phase 2 trial (SWOG-9416/INT-0160) support the use of concomitant chemoradiation followed by an attempt at surgical resection.

AB - Pancoast (superior sulcus tumors) comprise a subset of non-small-cell lung cancers that have a unique clinical presentation by virtue of the locoregional pattern of disease progression. We herein report a brief report on our group's pilot experience in managing these challenging lung neoplasms with an aggressive concomitant modality approach. These results and those of the recent Southwest Oncology-lead Intergroup prospective phase 2 trial (SWOG-9416/INT-0160) support the use of concomitant chemoradiation followed by an attempt at surgical resection.

KW - Concomitant chemoradiation

KW - Pancoast

KW - Superior sulcus

UR - http://www.scopus.com/inward/record.url?scp=0036159647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036159647&partnerID=8YFLogxK

U2 - 10.1097/00000421-200202000-00019

DO - 10.1097/00000421-200202000-00019

M3 - Article

C2 - 11823705

AN - SCOPUS:0036159647

VL - 25

SP - 90

EP - 92

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -